Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL2584928

COc1ccc(N2CCN(c3ccc(OC)cc3)C2=S)cc1.COc1ccc(N2CCN(c3ccc(OC)cc3)C2=S)cc1.O=S(=O)([O-])C(F)(F)F.[Ag+]

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Trifluoromethanesulfonic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOX4 Q9NPH5 2/20 0.50
LMNA P02545 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
NPC1 O15118 1/20 0.42
PKM P14618 1/20 0.42
PKLR P30613 1/20 0.42
RAB9A P51151 1/20 0.42
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA4 P22748 1/20 0.41
CA7 P43166 1/20 0.41
HSD17B10 Q99714 1/20 0.40
KCNH2 Q12809 1/20 0.40
HSD11B1 P28845 1/20 0.40
HTR7 P34969 1/20 0.39
HTT P42858 1/20 0.39
GAA P10253 1/20 0.39
PTGS2 P35354 3/20 0.39
PTGS1 P23219 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2579648 0.82 HTR3E (0.48) SMN1; SMN2NPC1PKMRAB9ACA1
Hydrochloric Acid SCHEMBL2579274 0.78 GAA (0.46) SMN1; SMN2NPC1PKMRAB9ACA1
Thiourea SCHEMBL2584115 0.74 POLB (0.49) LMNASMN1; SMN2
Trifluoromethanesulfonic Acid SCHEMBL8373803 0.70 KCNH2 (0.45) NPC1PKMPKLRRAB9ACA1
Trifluoromethanesulfonic Acid SCHEMBL454992 0.69 PKM (0.47) NPC1PKMPKLRRAB9ACA1
Trifluoromethanesulfonic Acid SCHEMBL5828338 0.69 PKM (0.47) NPC1PKMPKLRRAB9ACA1
Trifluoromethanesulfonic Acid SCHEMBL1592826 0.69 PKM (0.47) NPC1PKMPKLRRAB9ACA1
Trifluoromethanesulfonic Acid SCHEMBL5146818 0.68 KCNH2 (0.46) NPC1PKMPKLRRAB9ACA1
SCHEMBL16789887 0.68 HTR3E (0.52) LMNATSHRSMN1; SMN2NPC1PKM
SCHEMBL20681675 0.67 NOX4 (1.00) NOX4LMNATSHRSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722897-B2 Metal complexes of thiourea and derivatives as metal delivering anti-cancer and anti-inflammatory agents GOLDPORP PHARMA LIMITED (CN) 2014-05-13 US claimed
US-20110269730-A1 Metal Complexes of Thiourea and Derivatives as Metal Delivering Anti-Cancer and Anti-Inflammatory Agents GOLDPORP PHARMA LIMITED (CN) 2011-11-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269730-A1 Metal Complexes of Thiourea and Derivatives as Metal Delivering Anti-Cancer and Anti-Inflammatory Agents CLIC1, SLC30A5, TIA1 NOX4 1963/4885LMNA 4644/4885TSHR 67/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.